Page last updated: 2024-09-05

darunavir and Critical Illness

darunavir has been researched along with Critical Illness in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	2 (100.00)	2.80

Authors

Authors	Studies
Andini, R; Bertolino, L; Corcione, A; Durante-Mangoni, E; Florio, LL; Mele, F; Murino, P; Zampino, R	1
Choi, EY; Choi, SH; Kim, EJ; Kim, Y; Kwon, YS; Lee, J; Lee, SY; Park, JS	1

Other Studies

2 other study(ies) available for darunavir and Critical Illness

Article	Year
Early experience with remdesivir in SARS-CoV-2 pneumonia. Infection, 2020, Volume: 48, Issue:5 Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Chemical and Drug Induced Liver Injury; Convalescence; Coronavirus Infections; COVID-19; Critical Illness; Darunavir; Drug Administration Schedule; Drug Combinations; Fatal Outcome; Humans; Hydroxychloroquine; Lopinavir; Multiple Organ Failure; Pandemics; Pneumonia, Viral; Ritonavir; RNA, Viral; SARS-CoV-2; Torsades de Pointes	2020
Use of Darunavir-Cobicistat as a Treatment Option for Critically Ill Patients with SARS-CoV-2 Infection. Yonsei medical journal, 2020, Volume: 61, Issue:9 Topics: Adult; Anti-HIV Agents; Betacoronavirus; Case-Control Studies; Cobicistat; Coronavirus Infections; COVID-19; Critical Illness; Darunavir; Female; HIV Protease Inhibitors; Humans; Intensive Care Units; Male; Middle Aged; Pandemics; Pneumonia, Viral; Republic of Korea; Retrospective Studies; SARS-CoV-2; Severity of Illness Index; Treatment Outcome	2020

Article

Year

Early experience with remdesivir in SARS-CoV-2 pneumonia.

Infection, 2020, Volume: 48, Issue:5

Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Chemical and Drug Induced Liver Injury; Convalescence; Coronavirus Infections; COVID-19; Critical Illness; Darunavir; Drug Administration Schedule; Drug Combinations; Fatal Outcome; Humans; Hydroxychloroquine; Lopinavir; Multiple Organ Failure; Pandemics; Pneumonia, Viral; Ritonavir; RNA, Viral; SARS-CoV-2; Torsades de Pointes

2020

Use of Darunavir-Cobicistat as a Treatment Option for Critically Ill Patients with SARS-CoV-2 Infection.

Yonsei medical journal, 2020, Volume: 61, Issue:9

Topics: Adult; Anti-HIV Agents; Betacoronavirus; Case-Control Studies; Cobicistat; Coronavirus Infections; COVID-19; Critical Illness; Darunavir; Female; HIV Protease Inhibitors; Humans; Intensive Care Units; Male; Middle Aged; Pandemics; Pneumonia, Viral; Republic of Korea; Retrospective Studies; SARS-CoV-2; Severity of Illness Index; Treatment Outcome

2020